Breast Implant Illness (BII): What UK Women Need to Know in 2026

By Dr Shweta Aggarwal | Consultant Plastic & Reconstructive Surgeon | Dual-trained Oncoplastic Breast Surgeon | Full Member, BAAPS & ABS

Published: April 2026  |  Reviewed by: Dr Shweta Aggarwal, GMC Registered Specialist

Quick Answer

Breast implant illness (BII) is a term used to describe a range of systemic symptoms — including fatigue, brain fog, joint pain and skin problems — that some women attribute to their breast implants. BII is not yet a formally recognised medical diagnosis, and its biological mechanism is not fully understood. However, the symptoms reported by affected women are real, and a significant number experience improvement after implant removal. Equally, other causes of these symptoms must be carefully investigated before surgery is considered. If you are concerned about symptoms potentially related to your implants, a thorough consultation — not a rushed decision — is the right starting point.

If you have breast implants and have been experiencing symptoms you cannot fully explain — persistent fatigue, mental fog, widespread joint pain, recurrent infections, or skin and hair changes — you may have come across the term breast implant illness. You may also have found that when you raised this with your GP, the response was uncertain, sceptical, or dismissive.

That experience is frustrating and, for many women, isolating. The difficulty is that BII sits in genuinely complex medical territory: the symptoms are real and reported consistently by large numbers of women, yet the scientific understanding of what causes them, and whether implants are directly responsible, remains incomplete. This article sets out what we currently know, what the evidence shows about outcomes after removal, and what a responsible approach to investigation and decision-making looks like.

What is Breast Implant Illness?

BII is a patient-coined term describing a constellation of systemic symptoms that some women with breast implants report. It is not currently listed as a formal medical diagnosis in UK or international clinical guidelines, which means there is no agreed diagnostic test, no standardised criteria, and no official treatment pathway.

The most commonly reported symptoms include:

• Chronic fatigue and low energy disproportionate to lifestyle

• Cognitive difficulties — often described as brain fog, poor memory, or difficulty concentrating

• Joint and muscle pain

• Hair loss or changes in hair and skin texture

• Recurrent infections or a sense of reduced immune resilience

• Thyroid dysfunction or hormonal irregularities

• Anxiety, low mood, and sleep disturbance

These symptoms are non-specific — meaning they can have many causes unrelated to implants. This is one reason why establishing a clear link between breast implants and systemic illness has proved scientifically difficult, and why thorough investigation before considering surgery is so important.

What Does the Evidence Currently Show?

The scientific literature on BII is evolving. Several important points can be stated with reasonable confidence, and it is worth being clear about what is established, what is emerging, and what remains uncertain.

The symptoms are real and consistently reported

Large patient surveys and registry data have documented that a significant number of women with breast implants report systemic symptoms similar to those described above. This consistency across different countries, implant types, and time periods is meaningful, and the medical community is increasingly taking the symptom pattern seriously — even where the precise mechanism is not yet understood.

A formal causal link has not been established

At present, no large-scale controlled study has definitively established that breast implants cause the systemic symptoms grouped under the BII label. This does not mean the link does not exist — absence of proof is not proof of absence — but it does mean that clinical caution is warranted. Attributing a complex symptom pattern entirely to implants without ruling out other causes risks missing a treatable underlying condition.

Symptom improvement after explant is well documented

This is perhaps the most clinically significant piece of evidence. Multiple studies and large patient cohorts have reported meaningful improvement in BII-related symptoms following implant removal. Rates of improvement vary across studies, but a substantial proportion of patients — in some series, the majority — report feeling better after explant. This is an important finding and should be taken seriously in clinical decision-making.

An Important Nuance on Capsule Removal

There is a widespread belief among BII patients that en bloc capsulectomy — removal of the implant and its surrounding capsule in one intact piece — is essential for symptom resolution. The current evidence does not support this as a universal requirement. Several studies have found that symptom improvement following explant does not appear to differ significantly between patients who had en bloc removal and those who had the implant removed without full capsule excision.

This is a clinically important point: en bloc capsulectomy is a more complex, technically demanding procedure that carries greater surgical risk and is not always anatomically possible. It may be appropriate in specific circumstances — such as suspected BIA-ALCL or implant rupture — but it is not automatically the right choice for every BII patient. I discuss the most appropriate technique for each patient individually at consultation, based on their specific anatomy and circumstances.

Ruling Out Other Causes: Why This Step Matters

Before attributing symptoms to breast implants, it is essential to investigate other potential causes. Many of the symptoms associated with BII — fatigue, joint pain, cognitive changes,

hair loss — overlap significantly with a range of common and treatable conditions, including:

• Thyroid disorders (hypothyroidism in particular)

• Autoimmune conditions such as lupus, rheumatoid arthritis, or Sjögren's syndrome

• Iron deficiency anaemia

• Vitamin D deficiency

• Perimenopause and hormonal changes

• Depression and anxiety disorders

A responsible approach to a patient presenting with possible BII begins with a thorough history and appropriate blood tests to rule out these conditions. This is not a way of dismissing the patient's experience — it is good medicine. A woman who has undiagnosed hypothyroidism and believes her symptoms are caused by her implants will not feel better after surgery. A woman who has both thyroid dysfunction and a genuine inflammatory response to her implants needs both conditions addressed.

At consultation, I take a full history of your symptoms, their timeline relative to implant placement, and any investigations already carried out. Where appropriate, I will recommend further blood tests before we discuss surgical options.

The NHS Position on BII

The NHS does not currently fund breast implant removal on the basis of BII symptoms alone. Funding may be available where there is a specific clinical complication — such as implant rupture, capsular contracture requiring treatment, or suspected BIA-ALCL — but not for the systemic symptom cluster that constitutes BII as patients typically describe it.

This reflects the current absence of a formal diagnostic category for BII rather than a judgement on the validity of patients' experiences. It means that for most women pursuing explant for BII, this will be a self-funded private procedure.

BII and BIA-ALCL: Understanding the Difference

It is important not to conflate BII with BIA-ALCL (breast implant-associated anaplastic large cell lymphoma). These are distinct conditions.

BIA-ALCL is a rare but serious form of lymphoma that has been associated specifically with textured breast implants. It typically presents as a late seroma — a collection of fluid around the implant — often years after surgery. It is a recognised medical diagnosis with clear diagnostic criteria and treatment pathways. If you have textured implants and develop a new, unexplained fluid collection, you should be assessed promptly.

BII, by contrast, refers to systemic symptoms without a confirmed cancer diagnosis and is not linked specifically to textured implants. The two conditions require different investigations and different clinical approaches. If you are concerned about either, please seek assessment from a specialist.

Considering Explant Surgery: What a Responsible Approach Looks Like

If, after thorough investigation, you and your surgeon conclude that implant removal is appropriate, the following considerations apply:

• Surgery should be performed by a GMC-registered plastic surgeon with experience in explant procedures, in a CQC-registered facility

• The decision about whether to perform capsulectomy — and what type — should be based on your individual anatomy, the condition of the capsule, and the clinical picture, not on a fixed protocol driven by patient demand

• Realistic expectations are essential: improvement in symptoms after explant is well documented but cannot be guaranteed for any individual patient

• The impact on breast appearance should be discussed fully — many patients benefit from combining removal with a breast lift, though this is an individual decision

Frequently Asked Questions

How do I know if my symptoms are BII or something else?

There is no single test for BII. The most important first step is a thorough review of your symptoms and appropriate blood tests to exclude other causes — thyroid function, full blood count, inflammatory markers, autoimmune screen, vitamin D, and iron studies are a reasonable starting point. If investigations are normal and your symptoms began or worsened after implant placement, BII becomes a more credible explanation. This should be assessed in consultation with a specialist who takes the time to take a proper history.

Will removing my implants cure my BII symptoms?

Symptom improvement after explant is well documented, and a meaningful proportion of patients report feeling significantly better following removal. However, improvement cannot be guaranteed for any individual. Some patients experience partial improvement, some experience complete resolution, and some see little change. Setting realistic expectations before surgery is essential. The evidence does suggest that waiting and hoping symptoms will resolve with implants in place is unlikely to be effective for women with genuine BII.

Do I need en bloc capsulectomy for BII?

Not necessarily. The current evidence does not show that en bloc removal produces better symptom outcomes than removal without full capsule excision. En bloc is a more complex procedure, carries greater surgical risk, and is not always anatomically feasible. The appropriate technique depends on your individual circumstances — the condition of the capsule, your anatomy, and whether there are specific indications such as rupture or suspected BIA-ALCL. I discuss this in detail at consultation.

My GP dismissed my concerns about BII. What should I do?

GPs vary significantly in their familiarity with BII, and dismissal is a common experience. You are entitled to request a referral to a specialist — either a plastic surgeon experienced in explant surgery or a rheumatologist if autoimmune symptoms are prominent. You do not need your GP's endorsement to seek a private consultation. Bring a written timeline of your symptoms and any test results you already have, as this helps a specialist assess your case efficiently.

Is BII the same as an autoimmune disease?

Not as currently understood, though the symptoms of BII overlap with several autoimmune conditions. Some researchers have proposed that breast implants may trigger an inflammatory or immune response in susceptible individuals, but this has not been confirmed as a mechanism. A small number of studies have found associations between breast implants and certain autoimmune conditions, but causation has not been established. Thorough investigation to rule out primary autoimmune disease is important before attributing symptoms solely to implants.

What happens to my breasts after implant removal?

Following explant, the breasts will initially appear deflated and may feel soft or loose, particularly if the implants were large or had been in place for many years. Over the following months, tissue gradually remodels — a process sometimes called fluffing. Many patients choose to combine removal with a breast lift to address skin laxity and restore shape. Whether a lift is appropriate depends on your anatomy, the degree of skin stretch, and your preferences, and is something I assess at consultation.

Book a Consultation

If you are experiencing symptoms you believe may be related to your breast implants, I offer a thorough, unhurried consultation. I will take a proper history, review any investigations already carried out, and give you an honest, evidence-based assessment of your options — with no pressure to proceed to surgery.

Call 0203 442 0065  |  admin@saggarwal.com  |  drshwetaaggarwal.com/contact

About the Author

Dr Shweta Aggarwal is a Consultant Plastic & Reconstructive Surgeon based in London, dual-trained in plastic surgery and oncoplastic breast surgery. She is a full member of the British Association of Aesthetic Plastic Surgeons (BAAPS) and the Association of Breast Surgery (ABS), and is registered on the GMC Specialist Register. She has performed more than 1,000 breast procedures and operates at Nuffield Health The Holly Hospital, Spire London East, and Skin Care Network Barnet.